IT1299198B1 - Sali nitrati di farmaci antiulcera - Google Patents

Sali nitrati di farmaci antiulcera

Info

Publication number
IT1299198B1
IT1299198B1 IT98MI000442A ITMI980442A IT1299198B1 IT 1299198 B1 IT1299198 B1 IT 1299198B1 IT 98MI000442 A IT98MI000442 A IT 98MI000442A IT MI980442 A ITMI980442 A IT MI980442A IT 1299198 B1 IT1299198 B1 IT 1299198B1
Authority
IT
Italy
Prior art keywords
salts
nitrated
och3
ulcer drugs
formula
Prior art date
Application number
IT98MI000442A
Other languages
English (en)
Italian (it)
Inventor
Soldato Piero Del
Original Assignee
Nicox Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IT98MI000442A priority Critical patent/IT1299198B1/it
Application filed by Nicox Sa filed Critical Nicox Sa
Priority to CA002322493A priority patent/CA2322493A1/en
Priority to ES99911708T priority patent/ES2226357T3/es
Priority to CNB998035343A priority patent/CN1249053C/zh
Priority to KR1020007009693A priority patent/KR20010041522A/ko
Priority to PT99911708T priority patent/PT1068196E/pt
Priority to EP99911708A priority patent/EP1068196B1/en
Priority to PCT/EP1999/001226 priority patent/WO1999045004A1/en
Priority to BR9908428-7A priority patent/BR9908428A/pt
Priority to DE69919341T priority patent/DE69919341T2/de
Priority to SI9930655T priority patent/SI1068196T1/xx
Priority to AU30303/99A priority patent/AU752919B2/en
Priority to JP2000534547A priority patent/JP2002505328A/ja
Priority to RU2000122968/04A priority patent/RU2228331C2/ru
Priority to HU0100853A priority patent/HUP0100853A3/hu
Priority to IL13772199A priority patent/IL137721A0/xx
Priority to DK99911708T priority patent/DK1068196T3/da
Priority to AT99911708T priority patent/ATE273297T1/de
Priority to US09/622,068 priority patent/US6503929B1/en
Publication of ITMI980442A1 publication Critical patent/ITMI980442A1/it
Application granted granted Critical
Publication of IT1299198B1 publication Critical patent/IT1299198B1/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/48Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IT98MI000442A 1998-03-05 1998-03-05 Sali nitrati di farmaci antiulcera IT1299198B1 (it)

Priority Applications (19)

Application Number Priority Date Filing Date Title
IT98MI000442A IT1299198B1 (it) 1998-03-05 1998-03-05 Sali nitrati di farmaci antiulcera
JP2000534547A JP2002505328A (ja) 1998-03-05 1999-02-25 抗潰瘍医薬の硝酸塩
CNB998035343A CN1249053C (zh) 1998-03-05 1999-02-25 抗溃疡药物硝酸盐
KR1020007009693A KR20010041522A (ko) 1998-03-05 1999-02-25 항-궤양의 질산염 약제
PT99911708T PT1068196E (pt) 1998-03-05 1999-02-25 Sais nitratos de medixamentos anti-ulceras
EP99911708A EP1068196B1 (en) 1998-03-05 1999-02-25 Nitrate salt of anti-ulcer medicine
PCT/EP1999/001226 WO1999045004A1 (en) 1998-03-05 1999-02-25 Nitrate salt of anti-ulcer medicine
BR9908428-7A BR9908428A (pt) 1998-03-05 1999-02-25 Sais de nitrato, composições, uso de sal e composição, e, processo para preparação de sais de nitrato
CA002322493A CA2322493A1 (en) 1998-03-05 1999-02-25 Nitrate salt of anti-ulcer medicine
SI9930655T SI1068196T1 (en) 1998-03-05 1999-02-25 Nitrate salt of anti-ulcer medicine
AU30303/99A AU752919B2 (en) 1998-03-05 1999-02-25 Nitrate salt of anti-ulcer medicine
ES99911708T ES2226357T3 (es) 1998-03-05 1999-02-25 Nitratos que forman parte de un medicamento antiulceroso.
RU2000122968/04A RU2228331C2 (ru) 1998-03-05 1999-02-25 Нитратные соли гетероциклических соединений, способ их получения и фармацевтические композиции на их основе
HU0100853A HUP0100853A3 (en) 1998-03-05 1999-02-25 Nitrate salt of anti-ulcer medicine and pharmaceutical compositions containing the same compounds
IL13772199A IL137721A0 (en) 1998-03-05 1999-02-25 Nitrate salt of anti-ulcer medicine
DK99911708T DK1068196T3 (da) 1998-03-05 1999-02-25 Salpetersyresalt af antiulcuslægemidler
AT99911708T ATE273297T1 (de) 1998-03-05 1999-02-25 Salpetersäuresalz von antiulcus arzneimitteln
US09/622,068 US6503929B1 (en) 1998-03-05 1999-02-25 Nitrate salt of anti-ulcer medicine
DE69919341T DE69919341T2 (de) 1998-03-05 1999-02-25 Salpetersäuresalz von antiulcus arzneimitteln

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT98MI000442A IT1299198B1 (it) 1998-03-05 1998-03-05 Sali nitrati di farmaci antiulcera

Publications (2)

Publication Number Publication Date
ITMI980442A1 ITMI980442A1 (it) 1999-09-05
IT1299198B1 true IT1299198B1 (it) 2000-02-29

Family

ID=11379185

Family Applications (1)

Application Number Title Priority Date Filing Date
IT98MI000442A IT1299198B1 (it) 1998-03-05 1998-03-05 Sali nitrati di farmaci antiulcera

Country Status (19)

Country Link
US (1) US6503929B1 (https=)
EP (1) EP1068196B1 (https=)
JP (1) JP2002505328A (https=)
KR (1) KR20010041522A (https=)
CN (1) CN1249053C (https=)
AT (1) ATE273297T1 (https=)
AU (1) AU752919B2 (https=)
BR (1) BR9908428A (https=)
CA (1) CA2322493A1 (https=)
DE (1) DE69919341T2 (https=)
DK (1) DK1068196T3 (https=)
ES (1) ES2226357T3 (https=)
HU (1) HUP0100853A3 (https=)
IL (1) IL137721A0 (https=)
IT (1) IT1299198B1 (https=)
PT (1) PT1068196E (https=)
RU (1) RU2228331C2 (https=)
SI (1) SI1068196T1 (https=)
WO (1) WO1999045004A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
AU772188B2 (en) 1998-11-17 2004-04-08 Nitromed, Inc. Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
CA2393724A1 (en) 1999-12-23 2001-06-28 Nitromed, Inc. Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
IT1317735B1 (it) * 2000-01-26 2003-07-15 Nicox Sa Sali di agenti antimicrobici.
SE0002476D0 (sv) 2000-06-30 2000-06-30 Astrazeneca Ab New compounds
JP4092203B2 (ja) 2000-12-21 2008-05-28 ニトロメッド,インク. 新規のシクロオキシゲナーゼ2選択的阻害剤としての置換アリール化合物、組成物、および使用方法
US7129161B2 (en) * 2001-07-19 2006-10-31 Trikon Holdings Limited Depositing a tantalum film
WO2003103602A2 (en) 2002-06-11 2003-12-18 Nitromed, Inc. Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
AU2003279622A1 (en) 2002-06-28 2004-01-19 Nitromed, Inc. Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use
CA2491127A1 (en) 2002-07-03 2004-01-15 Nitromed, Inc. Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
AU2003261281A1 (en) 2002-07-29 2004-02-16 Nicox S.A. Cyclooxygenase- 2 selective inhibitors, compositions and methods of use
WO2004012659A2 (en) * 2002-08-01 2004-02-12 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
RU2304967C2 (ru) * 2005-05-26 2007-08-27 Государственное общеобразовательное учреждение высшего профессионального образования Казанский государственный медицинский университет Способ лечения язвенной болезни желудка и двенадцатиперстной кишки

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1397436A (en) * 1972-09-05 1975-06-11 Smith Kline French Lab Heterocyclic n-cyanoguinidines
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4375547A (en) * 1980-10-02 1983-03-01 Eli Lilly And Company N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine
EP0224612A1 (de) 1985-12-05 1987-06-10 HEUMANN PHARMA GMBH & CO Verfahren zur Herstellung von N-Cyano-N'-methyl-N"[2-[[(5-methyl-1H-imidazol-4-yl)methyl]thio]ethyl]guanidin
ES2053462T3 (es) * 1987-04-06 1994-08-01 Heumann Pharma Gmbh & Co Procedimiento para la produccion de derivados de nitroetano.
TW205041B (https=) * 1989-08-07 1993-05-01 Fujisawa Pharmaceutical Co

Also Published As

Publication number Publication date
HUP0100853A3 (en) 2003-01-28
JP2002505328A (ja) 2002-02-19
DE69919341T2 (de) 2005-09-08
HUP0100853A2 (hu) 2001-10-28
CN1291982A (zh) 2001-04-18
CN1249053C (zh) 2006-04-05
RU2228331C2 (ru) 2004-05-10
IL137721A0 (en) 2001-10-31
DK1068196T3 (da) 2004-11-29
AU752919B2 (en) 2002-10-03
CA2322493A1 (en) 1999-09-10
PT1068196E (pt) 2004-10-29
ATE273297T1 (de) 2004-08-15
EP1068196A1 (en) 2001-01-17
WO1999045004A1 (en) 1999-09-10
SI1068196T1 (en) 2004-12-31
US6503929B1 (en) 2003-01-07
DE69919341D1 (de) 2004-09-16
ES2226357T3 (es) 2005-03-16
EP1068196B1 (en) 2004-08-11
BR9908428A (pt) 2000-10-31
AU3030399A (en) 1999-09-20
ITMI980442A1 (it) 1999-09-05
KR20010041522A (ko) 2001-05-25

Similar Documents

Publication Publication Date Title
IT1299198B1 (it) Sali nitrati di farmaci antiulcera
DE69006984D1 (de) Thiazolidinedionederivate.
DE69705829D1 (de) Meta-substituierte phenylsulphonamidderivate
BRPI0413232B8 (pt) composto tendo atividade inibitória contra transportador dependente de sódio, composição farmacêutica compreendendo o composto, uso do composto na preparação de um medicamento e processo para a preparação do composto
MY114679A (en) Aroyl-piperidine derivatives
DE69303191D1 (de) Naphthalinderivate, ihre Herstellungsverfahren und synthetische Zwischenprodukte dafür
AU591390B2 (en) Arylcyclobutylalkyl amines and their use as antidepressive medicines
DK0447116T3 (da) Urinstof-derivater, deres fremstilling samt lægemidler indeholdende sådanne derivater
BR0013375A (pt) Composições farmacêuticas contendo derivados tiazolidinodiona e processo para sua preparação
NO872982D0 (no) Nye tetracykliske indolderivater.
DE69532739D1 (de) Kristalline Form eines Dihydro-2,3-benzodiazepinderivates
SE8802997D0 (sv) Aminderivat och dess salt, forfarande for framstellning derav och medel mot sar innehallande desamma
DE69528984D1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten
BR9908057A (pt) Derivados de amino antraciclinona
TH419A (th) กรรมวิธีในการเตรียมอนุพันธ์ของแอมีน
GB1117093A (en) Medicinal compositions with synergistic diuretic and anorexic activity
WO2001064671A3 (fr) Derives d'haloimidazole et leur utilisation en tant qu'antagonistes des recepteurs muscariniques m3 et serotoniques 5-ht4
TH18165A (th) สารยับยั้งการเกิดคีโมแทกซิของอีโอซีโนฟีล
TH16619A (th) อนุพันธ์อีเธอร์
TH25307A (th) อนุพันธ์ไบเฟนิล
TH25496A (th) เกลือของกรดคลาวูลานิก

Legal Events

Date Code Title Description
0001 Granted